BioCardia Inc BCDA:NASDAQ

RT Quote | NASDAQ | USD
Last | 05/13/22 EDT
1.40quote price arrow up+0.08 (+6.06%)
Volume
64,247
52 week range
1.10 - 5.10
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close1.40
  • 52 Week High5.10
  • 52 Week High Date06/21/21
  • 52 Week Low1.10
  • 52 Week Low Date05/12/22

Key Stats

  • Market Cap24.43M
  • Shares Out17.45M
  • 10 Day Average Volume0.10M
  • Dividend-
  • Dividend Yield-
  • Beta1.44
  • YTD % Change-27.84

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close1.40
  • 52 Week High5.10
  • 52 Week High Date06/21/21
  • 52 Week Low1.10
  • 52 Week Low Date05/12/22
  • Market Cap24.43M
  • Shares Out17.45M
  • 10 Day Average Volume0.10M
  • Dividend-
  • Dividend Yield-
  • Beta1.44
  • YTD % Change-27.84

RATIOS/PROFITABILITY

  • EPS (TTM)-0.76
  • P/E (TTM)-1.84
  • Fwd P/E (NTM)-1.67
  • EBITDA (TTM)-12.57M
  • ROE (TTM)-85.43%
  • Revenue (TTM)1.01M
  • Gross Margin (TTM)100.00%
  • Net Margin (TTM)-1,243.64%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date08/10/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On BioCardia Inc

There is no recent news for this security.

Profile

MORE
BioCardia, Inc. is a clinical-stage company. It is focused on developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases. Its lead therapeutic candidates are based on the CardiAMP Cell Therapy System, a platform which provides an autologous bone marrow-derived cell therapy for treatment in two clinical indications, such as ischemic heart failure and refractory angina resulting from chronic myocardial ischemia. Its second...
Andrew Blank
Independent Chairman of the Board
Peter Altman Ph.D.
President, Chief Executive Officer, Director
David McClung CPA
Chief Financial Officer
Address
320 Soquel Way
Sunnyvale, CA
94070-2718
United States

Top Peers

SYMBOLLASTCHG%CHG
CANF
Can Fite Biopharma Ltd
0.8688+0.0398+4.79%
CYTH
Cyclo Therapeutics Inc
2.11-0.04-1.86%
BBI
Brickell Biotech Inc
0.1863-0.0206-9.9565%
ONTX
Onconova Therapeutics Inc
1.08+0.04+3.85%
MNPR
Monopar Therapeutics Inc
2.02+0.17+9.19%